Literature DB >> 21387202

Androgen deficiency in heart failure.

Gülmisal Güder1, Bruno Allolio, Christiane E Angermann, Stefan Störk.   

Abstract

Androgen deficiency is a hormonal disorder that is frequently observed in advanced chronic conditions. A reduction of androgen blood levels may be cause or consequence of the disease, or both. Typical symptoms, such as fatigue or muscle weakness, may be particularly aggravated in heart failure, and disease severity may be indirectly affected by low levels of androgen. Recently, androgen replacement therapy has been suggested as a new treatment option of heart failure symptoms, and placebo-controlled pilot trials showed a modest improvement of physical performance. However, testosterone replacement in elderly patients is not without risks, and the benefit-risk ratio for such adjunct treatment is unclear. This review focuses on the general effects of androgens on the cardiovascular system and outlines expected benefits and suspected side effects of testosterone replacement therapy in patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21387202     DOI: 10.1007/s11897-011-0053-9

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  55 in total

Review 1.  Androgen replacement therapy in the aging male--a critical evaluation.

Authors:  A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

2.  Acute haemodynamic effects of testosterone in men with chronic heart failure.

Authors:  Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

3.  Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.

Authors:  Kay-Tee Khaw; Mitch Dowsett; Elizabeth Folkerd; Sheila Bingham; Nicholas Wareham; Robert Luben; Ailsa Welch; Nicholas Day
Journal:  Circulation       Date:  2007-11-26       Impact factor: 29.690

4.  Endogenous sex hormones and cardiovascular disease incidence in men.

Authors:  Johan Arnlöv; Michael J Pencina; Shreyasee Amin; Byung-Ho Nam; Emelia J Benjamin; Joanne M Murabito; Thomas J Wang; Philip E Knapp; Ralph B D'Agostino; Shalendar Bhasin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2006-08-01       Impact factor: 25.391

Review 5.  Androgens and osteoporosis.

Authors:  Peter R Ebeling
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

Review 6.  Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.

Authors:  Sadeka Shahani; Milena Braga-Basaria; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

Review 7.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

Review 8.  Exercise based rehabilitation for heart failure.

Authors:  K Rees; R S Taylor; S Singh; A J S Coats; S Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

10.  Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure.

Authors:  John M Saxton; Irena Zwierska; Atish Mathur; Kevin S Channer
Journal:  BMC Cardiovasc Disord       Date:  2006-11-30       Impact factor: 2.298

View more
  1 in total

1.  Testosterone and cardiac mass and function in men with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).

Authors:  Catherine Kim; Ionut Bebu; Barbara Braffett; Patricia A Cleary; Valerie Arends; Michael Steffes; Hunter Wessells; Trevor Orchard; Aruna V Sarma
Journal:  Clin Endocrinol (Oxf)       Date:  2016-01-25       Impact factor: 3.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.